Volunteer Received Experimental Monoclonal Antibody against Malaria (IMAGE)
Caption
Research Nurse Jennifer Cunningham, B.S.N., looks on as a healthy volunteer receives an infusion of CIS43LS, an experimental monoclonal antibody against malaria, as part of a Phase 1 clinical trial.
Credit
NIAID
Usage Restrictions
None
License
Licensed content